Conditional approval extended through December 2026 for the treatment of CID in dogs CID confirmatory effectiveness trial expected to conclude in February 2026, ahead of FDA’s June deadline – 51 dogs ...
EXZOLTâ„¢ CATTLE-CA1 is the first in its class and the only product conditionally approved for both the prevention and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback